Register Now
Course Information

CME-certified Satellite Breakfast Symposium, preceding the 60th ASH Annual Meeting
Friday, November 30, 2018 – 7:00 – 11:00 am
Manchester Grand Hyatt San Diego - Coronado ABC
San Diego, CA

Join us at Riding the Wave: Clinical Management of Myeloid Malignancies in an Era of Novel Therapies

The complimentary symposium will provide an in-depth and up-to-date review of research related to the biology, prognosis, natural history, and therapeutic management of patients with paroxysmal nocturnal hemoglobinuria (PNH), myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and myeloid malignancies. The program will bring leaders in disease research and clinical practice together to explore solutions to improve the care of patients.

By attending, you will be able to:

  • Critically appraise results of research on the evolving role of chimeric antigen receptor-T cell (CAR-T) therapy in myeloid malignancies;
  • Provide an in-depth overview of the efficacy and side effects of combination therapies for acute myeloid leukemia;
  • Summarize the prognostic implications and treatment considerations for idiopathic cytopenia of undetermined significance (ICUS), clonal hematopoiesis of indeterminate potential (CHIP), and clonal cytopenias of undetermined significance (CCUS);
  • Describe the diagnostic complexities and treatment options for paroxysmal nocturnal hemoglobinuria (PNH);
  • Describe the genomic mutations in overlap syndromes, prognostic implications, and treatment options;
  • Identify the most recent indications and strategies for bone marrow transplant in patients with acute myeloid leukemia or myelodysplastic syndrome.

Who Should Attend?

The satellite symposium is designed for an international audience including medical oncologists, hematologists, clinical and translational researchers, and other physicians and allied health care professionals treating patients with MDS, PHN, AML, and myeloid malignancies. In addition, members of patient advocacy groups will benefit from this program.

This is a Satellite Symposium organized by the Cleveland Clinic Taussig Cancer Institute Leukemia Program and Aplastic Anemia and MDS International Foundation, preceding the 60th ASH Annual Meeting.